Department of Dermatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina; the Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, California; and Fort HealthCare, Fort Atkinson, Wisconsin.
Obstet Gynecol. 2021 Apr 1;137(4):731-746. doi: 10.1097/AOG.0000000000004321.
Hidradenitis suppurativa is a chronic immune-mediated inflammatory skin disease with a prevalence of 0.1-1%, characterized by nodules and abscesses in the axillae, groin, and inframammary areas, sometimes developing into tunnels (or fistulas) and scars. Because hidradenitis suppurativa is more common in women and in those aged 18-40 years, obstetrician-gynecologists (ob-gyns) have the opportunity to diagnose, educate, initiate treatment, and coordinate care with ancillary health care professionals. The recently published North American treatment guidelines, along with management information for patients with hidradenitis suppurativa who are pregnant or breastfeeding, are summarized. By diagnosing and optimizing hidradenitis suppurativa treatment early in the disease course, ob-gyns can reduce morbidity, with the potential to favorably alter disease trajectory.
化脓性汗腺炎是一种慢性免疫介导的炎症性皮肤病，患病率为 0.1%-1%，其特征为腋窝、腹股沟和乳晕下区域出现结节和脓肿，有时会发展成瘘管（或窦道）和瘢痕。由于化脓性汗腺炎在女性和 18-40 岁人群中更为常见，妇产科医生（ob-gyns）有机会进行诊断、教育、启动治疗，并与辅助保健专业人员协调护理。总结了最近发布的北美治疗指南，以及针对妊娠或哺乳期化脓性汗腺炎患者的管理信息。通过在疾病早期诊断和优化化脓性汗腺炎的治疗，妇产科医生可以降低发病率，并有可能改变疾病的进程。
